Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
---|
10/30/2003 | US20030203431 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
10/30/2003 | US20030203430 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
10/30/2003 | US20030203429 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
10/30/2003 | US20030203428 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chondrocytes by contacting blood with polypeptide; cancer diagnosis |
10/30/2003 | US20030203411 Methods of minicell-based delivery |
10/30/2003 | US20030203402 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
10/30/2003 | US20030203401 Comprises nucleotide sequences coding membrane protein for diagnosing, preventing and treating cell proliferative, inflammatory or tumor disorders |
10/30/2003 | US20030203361 13 human colon and colon cancer associated proteins |
10/30/2003 | US20030202988 Attenuated mutant; induce immunology response |
10/30/2003 | US20030202976 Methods and reagents for diagnosis and treatment of diabetes |
10/30/2003 | US20030202975 Using monoclonal antibodies; shrinkage of solid tumors |
10/30/2003 | US20030202971 Genetic engineering; binding polypeptide to antibody ; screening, modulation, calibration |
10/30/2003 | US20030202937 Eubacterium; membrane protein; detecting signal moderated by binding |
10/30/2003 | CA2483327A1 Oligonucleotides from coding sequences for the surface component of ptlvenvelope proteins and uses thereof |
10/30/2003 | CA2482995A1 Low-cost production of peptides |
10/30/2003 | CA2482764A1 Cell wall mannoproteins and active epitopes from candida albicans and antibodies recognizing them |
10/30/2003 | CA2482368A1 Cytokine receptor |
10/30/2003 | CA2481507A1 Compositions and methods for the diagnosis and treatment of tumor |
10/30/2003 | CA2481411A1 Phospholipases, nucleic acids encoding them and methods for making and using them |
10/30/2003 | CA2480404A1 Fc receptor homolog, reagents, and uses thereof |
10/29/2003 | EP1357190A1 Methods and markers for simple transformation and selection of recombinant ciliates |
10/29/2003 | EP1357189A2 Elicitor of the hypersensitive response in plants |
10/29/2003 | EP1357187A1 Novel physiologically active peptide and use thereof |
10/29/2003 | EP1356300A2 Oomycete ftsz-mt as a target for antimicrobial-specific biocides |
10/29/2003 | EP1356298A2 Diagnosis and treatment of disease |
10/29/2003 | EP1356121A2 Improved methods for protein identification, characterization and sequencing by tandem mass spectrometry |
10/29/2003 | EP1356110A2 Non-invasive method for detecting target rna |
10/29/2003 | EP1356076A1 Methods and compositions for extracting proteins from cells |
10/29/2003 | EP1356074A2 Industrial-scale serum-free production of recombinant proteins in mammalian cells |
10/29/2003 | EP1356069A2 Enhanced transfection system |
10/29/2003 | EP1356068A2 Method for secretory production of glycoprotein having human-type sugar chain using plant cell |
10/29/2003 | EP1356060A2 Twin-arginine translocation in bacillus |
10/29/2003 | EP1356052A2 Prokaryotically produced antibodies and uses thereof |
10/29/2003 | EP1356046A2 Cytokine receptor zcytor19 |
10/29/2003 | EP1356043A2 Novel proteins and nucleic acids encoding same and antibodies directed against these proteins |
10/29/2003 | EP1356042A2 Carbohydrate-associated proteins |
10/29/2003 | EP1356041A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
10/29/2003 | EP1356039A2 Down syndrome critical region 1-like 1 proteins |
10/29/2003 | EP1356036A2 Process and compositions for peptide, protein and peptidomimetic synthesis |
10/29/2003 | EP1356032A2 Human kinases |
10/29/2003 | EP1356028A2 Protein modification and maintenance molecules |
10/29/2003 | EP1355950A1 Antibodies for human cytochrome p450 2d6 |
10/29/2003 | EP1355947A2 Monoclonal antibodies specific for the e2 glycoprotein of hepatitis c virus and their use in the diagnosis, treatment, and prevention of hepatitis c |
10/29/2003 | EP1355943A2 Neurotransmitter transporters |
10/29/2003 | EP1355942A2 Glp-1 fusion proteins |
10/29/2003 | EP1355939A2 Interferons, uses and compositions related thereto |
10/29/2003 | EP1355936A2 Polymer conjugates of neublastin and methods of using same |
10/29/2003 | EP1355935A2 Secreted proteins |
10/29/2003 | EP1355934A2 Compositions and methods relating to lung specific genes and proteins |
10/29/2003 | EP1355933A2 Iron regulating protein-2 (irp-2) as a diagnostic for neurodegenerative diseases |
10/29/2003 | EP1355930A2 A method for identification, isolation and production of antigens to a specific pathogen |
10/29/2003 | EP1355928A1 Universal carrier for targeting molecules to gb3 receptor expressing cells |
10/29/2003 | EP1355925A2 Long peptides of 22-45 amino acid residues that induce and/or enhance antigen specific immune responses |
10/29/2003 | EP1355922A2 Stress proteins and peptides and methods of use thereof |
10/29/2003 | EP1355918A2 Recombinant protective protein from $i(streptococcus pneumoniae) |
10/29/2003 | EP1355917A2 Compositions and methods relating to breast specific genes and proteins |
10/29/2003 | EP1009804B1 Nucleic acid sequences encoding capsaicin receptor and capsaicin receptor-related polypeptides and uses thereof |
10/29/2003 | EP0996728B1 IMPROVED ANTI-IgE ANTIBODIES AND METHODS OF IMPROVING ANTIBODIES |
10/29/2003 | EP0920501B1 Neuritin, a neurogene |
10/29/2003 | EP0832121B1 Methods for purifying authentic igf from yeast hosts |
10/29/2003 | EP0763105B1 Isolated nucleic acid molecule coding for fibroblast activation protein alpha and uses thereof |
10/29/2003 | EP0745128B1 Hepatitis b virus mutants, reagents and methods for detection |
10/29/2003 | EP0703985B1 Recombinant stratum corneum chymotryptic enzyme (scce) |
10/29/2003 | EP0682710B1 Isolation process using immobilized proteins with specific binding capacities |
10/29/2003 | EP0627000B1 Mammalian expression systems for hcv proteins |
10/29/2003 | EP0602193B1 Enhanced expression in plants |
10/29/2003 | EP0546118B1 Transferrin binding proteins from neisseria gonorrhoeae and neisseria meningitidis |
10/29/2003 | EP0293394B2 Novel thrombolytic proteins |
10/29/2003 | CN1452661A Viral vectors for use in monitoring HIV drug resistance |
10/29/2003 | CN1452659A Corynebacterium glutamicum genes encoding metabolic pathway proteins |
10/29/2003 | CN1452658A Process for production of human interferon alpha from genetically engineered yeast |
10/29/2003 | CN1452656A Lipoxygenase |
10/29/2003 | CN1452636A Human monoclonal antibodies to dendritis cells |
10/29/2003 | CN1452635A Recombinant fusion protein for diagnosis of tsutsugamushi disease |
10/29/2003 | CN1452633A Mammalian genes, related reagent and methods |
10/29/2003 | CN1451748A Method for preparing interferon |
10/29/2003 | CN1451666A Recombinant fusion resisting tomur attack and transfer |
10/29/2003 | CN1125877C Hepatitis G. Virus and molecular cloning thereof |
10/28/2003 | US6639063 Signal peptide directs the secretion of a polypeptide when located at the amino terminus of a polypeptide |
10/28/2003 | US6639060 DNA segment encoding a receptor protein related to the erbB proto-oncogene family which previously has not been known; tool for screening for anticancer agents |
10/28/2003 | US6639057 Monoclonal antibody against human telomerase catalytic subunit |
10/28/2003 | US6639055 Method for making humanized antibodies |
10/28/2003 | US6639050 Synthetic genes for plant gums and other hydroxyproline-rich glycoproteins |
10/28/2003 | US6638907 Laminin 8 and methods for its use |
10/28/2003 | US6638767 Methods for delivering compounds into a cell |
10/28/2003 | US6638745 Antiinflammatory agents, anticarcinogenic agents; arteriosclerosis, psoriasis; gene therapy, diagnosis; genetic engineering |
10/28/2003 | US6638740 Chromatography, elution, ion exchanging |
10/28/2003 | US6638737 Over-expressing in host cell to increase yield of secreted polypeptide; signal sequence at N-terminus and endoplasmic reticulum retention signal at C-terminus |
10/28/2003 | US6638736 Gene expression inhibition; cancer and neurodegenerative disease diagnosis; molecular hybridization |
10/28/2003 | US6638735 Plasmid for gene expression in pichia ciferrii and transformation method using the same |
10/28/2003 | US6638512 Method for treating subjects by using BAGE tumor rejection antigen precursors or tumor rejection antigens |
10/28/2003 | US6638511 Mycobacterium polypeptides and nucleic acids encoding them for diagnosis and control of tuberculosis |
10/28/2003 | US6638510 Recombinant plasmid and a method of controlling the effects of Yersinia pestis |
10/28/2003 | US6638505 For prevention of influenza virus binding to cells, therapy of schizophrenia and diagnosing chronic viral disease associated with development of cancer |
10/28/2003 | CA2118010C Antibodies specific for carcinoma-associated antigens |
10/28/2003 | CA2095109C Process for production of exogenous gene or its product in plant cells |
10/23/2003 | WO2003087840A2 Protein involved in cancer |
10/23/2003 | WO2003087838A2 Compositions, methods and kits for immunochemical determination of mannan-binding lectin (mbl) |
10/23/2003 | WO2003087832A2 Diagnosis of carcinoma using raigi polypeptides |
10/23/2003 | WO2003087380A1 Derivatives of the nf-kappab inducing enzyme, their preparation and use |